Pro-Atherogenic Inflammatory Mediators in Inflammatory Bowel Disease Patients Increase the Risk of Thrombosis, Coronary Artery Disease, and Myocardial Infarction: A Scientific Dilemma-Reference-Cited by-同舟云学术

Pro-Atherogenic Inflammatory Mediators in Inflammatory Bowel Disease Patients Increase the Risk of Thrombosis, Coronary Artery Disease, and Myocardial Infarction: A Scientific Dilemma

Published:2020-09-19 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Kondubhatla Kaushik,Kaushal Ayush,Daoud Ali,Shabbir Hassan,Mostafa Jihan A

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference42 articles.

1. Inflammatory bowel disease: clinical aspects and treatments;Fakhoury M;J Inflamm Res,2014

2. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease;Seyedian SS;J Med Life,2019

3. Disease monitoring in inflammatory bowel disease;Chang S;World J Gastroenterol,2015

4. Inflammatory bowel disease: pathogenesis;Zhang YZ;World J Gastroenterol,2014

5. Inflammatory bowel disease as a risk factor for premature coronary artery disease;Ruisi P;J Clin Med Res,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-12α deficiency attenuates pressure overload-induced cardiac inflammation, hypertrophy, dysfunction, and heart failure progression;Frontiers in Immunology;2023-02-13

2. Evaluation of adalimumab effects on left ventricle performance by echocardiography indexes among patients with immunosuppressant refractory ulcerative colitis;Frontiers in Medicine;2023-01-06

3. Ulcerative colitis and cardiovascular disease. Case report;Systemic Hypertension;2023-01-03

4. Аtherosclerosis and cardiovascular risk in patients with inflammatory bowel disease;Terapevticheskii arkhiv;2021-12-15